Exploring the Resurgence of a Neglected Disease: Lessons From the 2023–2024 Mpox Outbreak in Rio de Janeiro, Brazil

作者：Mayara Secco Torres Silva, Carolina Coutinho, Thiago Silva Torres, Mônica Avelar Figueiredo Mafra Magalhães, Carolyn Yanavich, Amanda Echeverría-Guevara, Matheus Oliveira Bastos, Pedro da Silva Martins, Maira Braga Mesquita, Paula Pereira de Souza Reges, Maria Roberta Meneguetti, Ana Paula Lovetro Santana, M.A. Terra, Estêvão Portela Nunes, Flavia Cristina Serrão Lessa, Ronaldo I. Moreira, Eduardo Mesquita Peixoto, Karolyne Wolch de Almeida Paulo, Andryelle Cristina Sant’Ana, Edson Elias da Silva, Sandra Wagner Cardoso, Valdiléa G. Veloso, Beatriz Grinsztejn, for the Instituto Nacional de Infectologia Evandro Chagas (INI)–Fiocruz Mpox Study Group, João Paulo Bortot Soares, Giselle Hottz, Cícero Gomes dos Santos, Bruna Fabris Rendelli, Luciana Patricia Tuccori, Jadir Rodrigues Fagundes Neto, Lucilene Freitas, Mayumi Duarte Wakimoto, Kátia Martins Lopes de Azevedo, Rodrigo Escada, Maria Pia Diniz Ribeiro, Isabel Cristina Ferreira Tavares, Desirée Vieira Santos, Luiz Ricardo Siqueira Camacho, Leonardo Azevedo Silva Rosadas, Luísa de Rezende Cecilio Fares, Pedro Amparo, Hugo Boechat Andrade, José Ricardo Hildebrant Coutinho, Hugo Perazzo Pedroso Barbosa, Sandro Nazer, Guilherme Amaral Calvet, Rodrigo Caldas Menezes, Sandro Antônio Pereira · 发表于：Clinical Infectious Diseases · 年份：2024 · DOI：10.1093/cid/ciae290 · 被引用次数：5 · 研究领域：Poxvirus research and outbreaks、Bacillus and Francisella bacterial research、Zoonotic diseases and public health

Following the 2022 global mpox outbreak, diagnoses decreased worldwide, even in settings with limited vaccine access. In 2023-2024, a new outbreak emerged in Rio de Janeiro, Brazil, highlighting the importance of continuous surveillance, preventive measures such as vaccination in vulnerable populations, and treatment options, emphasizing equitable global health technology distribution.